Why the study?
Are elevated levels of soluble P-selectin a risk factor for a first episode of venous thromboembolism in patients with all types of cancer?
Are elevated levels of soluble P-selectin a risk factor for a first episode of venous thromboembolism in patients with all types of cancer?
Elevated soluble P-selectin may serve as a biomarker for predicting the first episode of venous thromboembolism in cancer patients.
In this issue of Blood , Ay and colleagues demonstrate that elevated levels of soluble P-selectin are a risk factor for a first episode of venous thromboembolism in patients with all types of cancer.
No takes yet. Share an insight, caveat, or question.
Frederick R. Rickles (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: